(MMC) Marsh & McLennan Companies - Ratings and Ratios
Insurance Broking, Risk Advisory, Consulting, Reinsurance, Health Benefits
Dividends
| Dividend Yield | 1.84% |
| Yield on Cost 5y | 3.21% |
| Yield CAGR 5y | 13.47% |
| Payout Consistency | 91.1% |
| Payout Ratio | 36.1% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 16.1% |
| Value at Risk 5%th | 26.9% |
| Relative Tail Risk | 1.46% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.72 |
| Alpha | -19.89 |
| CAGR/Max DD | 0.21 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.407 |
| Beta | 0.335 |
| Beta Downside | 0.273 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.07% |
| Mean DD | 5.53% |
| Median DD | 2.87% |
Description: MMC Marsh & McLennan Companies December 02, 2025
Marsh & McLennan Companies (MMC) is a global professional-services firm that delivers risk, strategy and people solutions through two primary divisions: Risk & Insurance Services, which provides risk-advice, risk-transfer, broking, analytics and program-management services; and Consulting, which offers health, wealth, career, and specialized management, strategic, economic and brand advisory services. Founded in 1871 and headquartered in New York, the company serves corporate, public-sector, insurance, association, professional-services and private-client customers worldwide.
Key performance indicators from the most recent fiscal year (2023) show total revenue of roughly $21.6 billion, with the Risk & Insurance Services segment contributing about 62 % of revenue and delivering an operating margin of 13 %. The Consulting segment, while smaller (≈ 38 % of revenue), has been growing at a 5-6 % annual rate, driven by rising demand for ESG-related risk consulting and workforce-transformation services. A sector-wide driver is the tightening of corporate balance sheets amid higher interest rates, which increases the appetite for sophisticated risk-transfer and cost-optimization solutions.
If you’re looking to deepen the quantitative analysis of MMC’s valuation dynamics, a quick look at ValueRay’s data dashboard can surface additional forward-looking metrics and scenario models to inform your research.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (4.13b TTM) > 0 and > 6% of Revenue (6% = 1.59b TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA 1.14pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 9.83% (prev 11.20%; Δ -1.37pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 5.34b > Net Income 4.13b (YES >=105%, WARN >=100%) |
| Net Debt (18.91b) to EBITDA (7.25b) ratio: 2.61 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.12 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (494.0m) change vs 12m ago -0.40% (target <= -2.0% for YES) |
| Gross Margin 42.28% (prev 43.06%; Δ -0.78pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 48.70% (prev 48.02%; Δ 0.67pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.66 (EBITDA TTM 7.25b / Interest Expense TTM 956.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.11
| (A) 0.04 = (Total Current Assets 23.70b - Total Current Liabilities 21.10b) / Total Assets 58.78b |
| (B) 0.46 = Retained Earnings (Balance) 26.95b / Total Assets 58.78b |
| (C) 0.12 = EBIT TTM 6.37b / Avg Total Assets 54.32b |
| (D) 0.51 = Book Value of Equity 22.07b / Total Liabilities 43.42b |
| Total Rating: 3.11 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 79.97
| 1. Piotroski 7.0pt |
| 2. FCF Yield 4.72% |
| 3. FCF Margin 19.33% |
| 4. Debt/Equity 1.41 |
| 5. Debt/Ebitda 2.61 |
| 6. ROIC - WACC (= 7.82)% |
| 7. RoE 28.30% |
| 8. Rev. Trend 79.43% |
| 9. EPS Trend 45.14% |
What is the price of MMC shares?
Over the past week, the price has changed by +2.41%, over one month by +1.87%, over three months by -7.83% and over the past year by -12.38%.
Is MMC a buy, sell or hold?
- Strong Buy: 4
- Buy: 1
- Hold: 12
- Sell: 3
- Strong Sell: 0
What are the forecasts/targets for the MMC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 211.9 | 13.8% |
| Analysts Target Price | 211.9 | 13.8% |
| ValueRay Target Price | 183.4 | -1.5% |
MMC Fundamental Data Overview December 09, 2025
P/E Trailing = 21.7749
P/E Forward = 19.3424
P/S = 3.3791
P/B = 5.8784
P/EG = 1.9956
Beta = 0.751
Revenue TTM = 26.45b USD
EBIT TTM = 6.37b USD
EBITDA TTM = 7.25b USD
Long Term Debt = 18.32b USD (from longTermDebt, last quarter)
Short Term Debt = 1.59b USD (from shortTermDebt, last quarter)
Debt = 21.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 18.91b USD (from netDebt column, last quarter)
Enterprise Value = 108.30b USD (89.39b + Debt 21.43b - CCE 2.51b)
Interest Coverage Ratio = 6.66 (Ebit TTM 6.37b / Interest Expense TTM 956.0m)
FCF Yield = 4.72% (FCF TTM 5.11b / Enterprise Value 108.30b)
FCF Margin = 19.33% (FCF TTM 5.11b / Revenue TTM 26.45b)
Net Margin = 15.60% (Net Income TTM 4.13b / Revenue TTM 26.45b)
Gross Margin = 42.28% ((Revenue TTM 26.45b - Cost of Revenue TTM 15.27b) / Revenue TTM)
Gross Margin QoQ = 38.69% (prev 44.15%)
Tobins Q-Ratio = 1.84 (Enterprise Value 108.30b / Total Assets 58.78b)
Interest Expense / Debt = 1.11% (Interest Expense 237.0m / Debt 21.43b)
Taxrate = 25.05% (253.0m / 1.01b)
NOPAT = 4.78b (EBIT 6.37b * (1 - 25.05%))
Current Ratio = 1.12 (Total Current Assets 23.70b / Total Current Liabilities 21.10b)
Debt / Equity = 1.41 (Debt 21.43b / totalStockholderEquity, last quarter 15.15b)
Debt / EBITDA = 2.61 (Net Debt 18.91b / EBITDA 7.25b)
Debt / FCF = 3.70 (Net Debt 18.91b / FCF TTM 5.11b)
Total Stockholder Equity = 14.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.02% (Net Income 4.13b / Total Assets 58.78b)
RoE = 28.30% (Net Income TTM 4.13b / Total Stockholder Equity 14.58b)
RoCE = 19.37% (EBIT 6.37b / Capital Employed (Equity 14.58b + L.T.Debt 18.32b))
RoIC = 13.83% (NOPAT 4.78b / Invested Capital 34.53b)
WACC = 6.01% (E(89.39b)/V(110.81b) * Re(7.25%) + D(21.43b)/V(110.81b) * Rd(1.11%) * (1-Tc(0.25)))
Discount Rate = 7.25% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.40%
[DCF Debug] Terminal Value 79.75% ; FCFE base≈4.58b ; Y1≈5.09b ; Y5≈6.66b
Fair Price DCF = 236.2 (DCF Value 115.71b / Shares Outstanding 489.9m; 5y FCF grow 12.84% → 3.0% )
EPS Correlation: 45.14 | EPS CAGR: 8.55% | SUE: 1.40 | # QB: 4
Revenue Correlation: 79.43 | Revenue CAGR: 5.82% | SUE: 0.47 | # QB: 0
EPS next Quarter (2026-03-31): EPS=3.24 | Chg30d=-0.003 | Revisions Net=+0 | Analysts=19
EPS next Year (2026-12-31): EPS=10.31 | Chg30d=-0.013 | Revisions Net=-2 | Growth EPS=+7.4% | Growth Revenue=+5.1%
Additional Sources for MMC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle